The result was that they do statistically significantly decrease the risk of lung cancer: for BCHE, Exp(β) = 0.571 (p < 0.05) and for GPx3 Exp(β) = 0.803 (p < 0.01). The gene discussed is GPX3; the disease is lung carcinoma.